Literature DB >> 113975

Urinary excretion and plasma levels of norepinephrine and epinephrine during diabetic ketoacidosis.

G Bolli, P Compagnucci, M G Cartechini, P De Feo, F Santeusanio, A Puxeddu, P Brunetti.   

Abstract

Sympathetic activity was determined in 13 ketoacidotic diabetics by evaluation of plasma and urinary catecholamines, before and in the course of medical management. Patients were divided into two groups. Group A (severe ketoacidosis, n = 5) and Group B (moderate ketoacidosis, = 8), depending on plasma glucose, pH and plasma bicarbonate levels. The results showed an enhanced sympathetic activity in all patients before treatment, with significant decrease during therapy. In Group A plasma catecholamines were higher than in Group B, both before and in the course of therapy. A significant correlation was found between basal plasma catecholamines and initial plasma glucose, plasma bicarbonate, hours of therapy and insulin dosage required to obtain plasma glucose levels below 150 mg/100 ml .These results, suggesting a close correlation between glycometabolic control and adrenergic activity, emphasize the role of the sympathetic nervous system as a powerful contrainsular factor in the pathogenesis and metabolic derangement of diabetic ketoacidosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113975     DOI: 10.1007/bf02581095

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  13 in total

1.  PLasma glucagon levels during rapid exsanguination with and without adrenergic blockade.

Authors:  C A Lindsey; G R Faloona; R H Unger
Journal:  Diabetes       Date:  1975-04       Impact factor: 9.461

2.  Adrenergic modulation of pancreatic glucagon secretion in man.

Authors:  J E Gerich; M Langlois; C Noacco; V Schneider; P H Forsham
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

3.  A sensitive and specific fluorimetric method for the determination of noradrenalin and adrenalin in human plasma.

Authors:  V Renzini; C A Brunori; C Valori
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

Review 4.  Isotope-derivative measurements of plasma norepinephrine and epinephrine in man.

Authors:  P E Cryer
Journal:  Diabetes       Date:  1976-11       Impact factor: 9.461

5.  Diabetic ketosis. Serial plasma growth hormone concentrations during therapy.

Authors:  P E Cryer; W H Daughaday
Journal:  Diabetes       Date:  1970-07       Impact factor: 9.461

6.  [Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment].

Authors:  R Assan; G Hautecouverture; S Guillemant; F Dauchy; P Protin; M Derot
Journal:  Pathol Biol (Paris)       Date:  1969-12

7.  Effect of metabolic control on urinary excretion and plasma levels of catecholamines in diabetics.

Authors:  G Bolli; M G Cartechini; P Compagnucci; S Malvicini; P De Feo; F Santeusanio; G Angeletti; P Brunetti
Journal:  Horm Metab Res       Date:  1979-10       Impact factor: 2.936

8.  Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  Plasma 11-hydroxycorticosteroid and growth hormone levels in acute medical illnesses.

Authors:  H S Jacobs; J D Nabarro
Journal:  Br Med J       Date:  1969-06-07

10.  Role of glucagon and other hormones in development of diabetic ketoacidosis.

Authors:  K G Alberti
Journal:  Lancet       Date:  1975-06-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.